NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract
By:
PRLog
November 26, 2025 at 18:55 PM EST
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties. Key Highlights of Persimonal®
Executive Statement "The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health." About NATCO NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry. www.natcohealthyliving.com Photos: (Click photo to enlarge) Source: NATCO, Inc Read Full Story - NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract | More news from this source Press release distribution by PRLog More NewsView More
Worried About Inflation? These 3 ETFs Offer Real Protection ↗
Today 11:10 EST
Klarna's Crypto Play: A Plan to Fix Its Profit Problem ↗
Today 8:36 EST
Via MarketBeat
Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care ↗
November 29, 2025
Via MarketBeat
SoFi Technologies: From Fintech Speculation to Profit Engine ↗
November 29, 2025
Via MarketBeat
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>